Discovery of novel covalent selective estrogen receptor degraders against endocrine-resistant breast cancer.
Journal Information
Full Title: Acta Pharm Sin B
Abbreviation: Acta Pharm Sin B
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Pharmacology & Pharmacy
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"with compounds29c (7ymk) can be accessed from the rcsb protein data bank ( www rcsb org ) 4 9 pk studies were conducted in balb/c female mice ( n = 3 mice/group)."
"Conflicts of interest The authors declare no conflicts of interest."
"The work was supported by National Key R&D Program of China (2020YFA0908800, 2021YFC2100300), 10.13039/100014717National Natural Science Foundation of China (82273774, 82073690, 81773557, 82173676, 82103994), the Fundamental Research Funds for the Central Universities of China (2042022kf0056), and the China Postdoctoral Science Foundation (2020M672435)."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025